Cytokinetics, Incorporated (CYTK)
NASDAQ: CYTK · Real-Time Price · USD
62.79
-0.12 (-0.19%)
At close: Oct 12, 2026, 4:00 PM EDT
61.54
-1.25 (-1.99%)
After-hours: Oct 12, 2026, 7:30 PM EDT
Cytokinetics Employees
Cytokinetics had 673 employees as of December 31, 2025. The number of employees increased by 175 or 35.14% compared to the previous year. That makes Cytokinetics the 17,806th largest employer in the world and 2,456th in the United States.
Employees
673
Change (1Y)
175
Growth (1Y)
35.14%
Revenue / Employee
$100,550
Profits / Employee
-$1,328,383
Market Cap
8.73B
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Dec 31, 2025 | 673 | 175 | 35.14% |
| Dec 31, 2024 | 498 | 75 | 17.73% |
| Dec 31, 2023 | 423 | 14 | 3.42% |
| Dec 31, 2022 | 409 | 156 | 61.66% |
| Dec 31, 2021 | 253 | 69 | 37.50% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| Caris Life Sciences | 1,846 |
| Ionis Pharmaceuticals | 1,480 |
| Axsome Therapeutics | 1,346 |
| Twist Bioscience | 979 |
| Arrowhead Pharmaceuticals | 711 |
| TG Therapeutics | 399 |
| Krystal Biotech | 295 |
| Kymera Therapeutics | 273 |
CYTK News
- 5 hours ago - Cytokinetics announces additional data from ACACIA-HCM trial at HFSA - TheFly
- 5 hours ago - Cytokinetics Announces Additional Data from ACACIA-HCM Presented at the HFSA Annual Scientific Meeting 2026 - GlobeNewsWire
- 4 days ago - Cytokinetics price target raised to $113 from $112 at RBC Capital - TheFly
- 10 days ago - Cytokinetics Announces Four Upcoming Presentations at the HFSA Annual Scientific Meeting 2026 - GlobeNewsWire
- 12 days ago - Cytokinetics announces start of ASPEN-HCM - TheFly
- 12 days ago - Cytokinetics Launches ASPEN-HCM: A Real-World Study Evaluating MYQORZO® (aficamten) in Symptomatic Obstructive Hypertrophic Cardiomyopathy - GlobeNewsWire
- 19 days ago - Cytokinetics Transcript: Bernstein Insights: Healthcare Leaders and Disruptors – 3rd Annual Healthcare Forum - Transcripts
- 25 days ago - Cytokinetics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire